Sponsor
LAPIX Therapeutics Inc.
Clinical research sponsor
Clinical trials
3 shownSafety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic ArthritisNCT06628206 · lead sponsor · 2024-12-15
RECRUITINGFirst-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641NCT05853835 · lead sponsor · 2023-10-30
COMPLETEDAn Observational Biomarker Study in Multiple Sclerosis (MS) PatientsNCT05663853 · lead sponsor · 2023-03-28
COMPLETEDSponsor roles
lead sponsor3
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.